BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1243527)

  • 1. Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
    Schulz KD; Del Pozo E; Lose KH; Künzig HJ; Geiger W
    Arch Gynakol; 1975 Dec; 220(1):83-7. PubMed ID: 1243527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine].
    Hauser GA
    Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
    Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premenstrual tension and functional infertility. Aetiology and treatment.
    Benedek-Jaszmann LJ; Hearn-Sturtevant MD
    Lancet; 1976 May; 1(7969):1095-8. PubMed ID: 57506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
    Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J
    Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
    Aydin Y; Atis A; Kaleli S; Uludağ S; Goker N
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):203-6. PubMed ID: 20206430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
    Kullander S
    Ann Chir Gynaecol; 1976; 65(4):227-33. PubMed ID: 970897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine for severe mastalgia.
    Mansel RE; Preece PE; Hughes LE
    Br Med J; 1977 May; 1(6072):1356. PubMed ID: 577188
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.
    Parlati E; Polinari U; Salvi G; Giorlandino C; Liberale I; Fiorella G; Dell'Acqua S
    Acta Obstet Gynecol Scand; 1987; 66(6):483-8. PubMed ID: 3321867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility.
    Pepperell RJ; Evans JH; Brown JB; Smith MA; Healy D; Burger HG
    Br J Obstet Gynaecol; 1977 Jan; 84(1):58-66. PubMed ID: 576585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment of benign breast diseases].
    Schulz KD
    Fortschr Med; 1980 Sep; 98(36):1359-64. PubMed ID: 7461541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
    Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
    Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin suppression in the treatment of premenstrual syndrome.
    Graham JJ; Harding PE; Wise PH; Berriman H
    Med J Aust; 1978 Nov; 2(3 Suppl):18-20. PubMed ID: 370525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine treatment of the premenstrual syndrome.
    Kullander S; Svanberg L
    Acta Obstet Gynecol Scand; 1979; 58(4):375-8. PubMed ID: 393053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.